Selskabets formål er at udføre rådgivende ingeniørvirksomhed og aktiviteter i naturlig tilknytning hertil.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 4.6 mia. | 385.3 mio. | 1.6 mia. | 670.3 mio. | 1542 | |
CVR: 13246009
Secondary names: NOVO NORDISK ENGINEERING A/S, NNE Pharmaplan A/S
Compared to 1.016 companies in Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik
Comparison is based on industry median values
NNE A/S demonstrates strong financial health with consistent revenue and profit growth over the past five years. Revenue surged from 1.42 billion DKK in 2021 to 4.56 billion DKK in 2025, while profit increased from 192 million DKK to 385 million DKK in the same period, indicating a robust upward trajectory. The company's equity has also strengthened significantly, rising from 364 million DKK in 2021 to 670 million DKK in 2025, reflecting solid financial stability. Key strengths include healthy profit margins and a strong equity position, positioning NNE A/S favorably within the engineering consulting industry. However, the lack of information on employee count and debt levels could present potential concerns for investors.
AI-generated summary
Companies in the same industry and area
CVR 11798691
CVR 41248831
CVR 44623528
CVR 25348168
CVR 42596345
companydata.dk